Find clinical trials for Alzheimer's Disease in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Montréal, QC, CAN:
administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...
Phase 2
Greenfield Park, Quebec, Canada and 96 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Greenfield Park, Quebec, Canada and 246 other locations
The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (inclu...
Phase 2
Greenfield Park, Quebec, Canada and 102 other locations
study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...
Phase 2
Montreal, Quebec, Canada and 204 other locations
This study is to be conducted in participants with early Alzheimer's Disease to test VY7523, a new drug being researched for treatm ...
Phase 1, Phase 2
Montreal, Quebec, Canada and 30 other locations
The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's...
Phase 2
Montreal, Quebec, Canada and 122 other locations
In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...
Phase 2
Montréal, Quebec, Canada and 137 other locations
The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease...
Phase 3
Greenfield Park, Quebec, Canada and 276 other locations
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...
Phase 3
Montréal, Quebec, Canada and 330 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Montréal, Quebec, Canada and 341 other locations
Clinical trials
Research sites
Resources
Legal